Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126696533 | 12669653 | 3 | F | 201505 | 20160824 | 20160819 | 20160826 | EXP | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-54045BP | BOEHRINGER INGELHEIM | 75.12 | YR | F | Y | 0.00000 | 20160826 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126696533 | 12669653 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 300 MG | U | 22512 | 150 | MG | CAPSULE | BID | |||||
| 126696533 | 12669653 | 2 | SS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | U | 22512 | |||||||||||
| 126696533 | 12669653 | 3 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 126696533 | 12669653 | 4 | C | TIKOSYN | DOFETILIDE | 1 | Unknown | 0 | |||||||||||
| 126696533 | 12669653 | 5 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | FORMULATION: DISKUS | 0 | ||||||||||
| 126696533 | 12669653 | 6 | C | COREG | CARVEDILOL | 1 | Unknown | 0 | |||||||||||
| 126696533 | 12669653 | 7 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | 0 | |||||||||||
| 126696533 | 12669653 | 8 | C | COZAAR | LOSARTAN POTASSIUM | 1 | Unknown | 0 | |||||||||||
| 126696533 | 12669653 | 9 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 126696533 | 12669653 | 10 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126696533 | 12669653 | 1 | Cerebrovascular accident prophylaxis |
| 126696533 | 12669653 | 2 | Atrial fibrillation |
| 126696533 | 12669653 | 3 | Product used for unknown indication |
| 126696533 | 12669653 | 4 | Atrial fibrillation |
| 126696533 | 12669653 | 5 | Product used for unknown indication |
| 126696533 | 12669653 | 6 | Product used for unknown indication |
| 126696533 | 12669653 | 7 | Product used for unknown indication |
| 126696533 | 12669653 | 8 | Product used for unknown indication |
| 126696533 | 12669653 | 9 | Product used for unknown indication |
| 126696533 | 12669653 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126696533 | 12669653 | HO |
| 126696533 | 12669653 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126696533 | 12669653 | Angioedema | |
| 126696533 | 12669653 | Dyspnoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126696533 | 12669653 | 1 | 201210 | 0 |